16.00 – 18.00

Registration – HOTEL BEST WESTERN LA MARINA

18.15 – 19.15

Welcome/Introduction - PALAIS DES CONGRES

OPENING KEYNOTE ADDRESS:

Rob RUIGROK, Grenoble, France

Structure and function of the influenza virus polymerase (O1)

19.30 – 21.30

Welcome Reception Buffet Dinner: Hotel Best Western La Marina

09.00 – 09.40

KEYNOTE TALK: Sarah CLEAVELAND, Glasgow, UK

Ecology of viral zoonoses: from individuals to ecosystems (O2)

Time

Speaker

Title

09.40 – 10.00

M. Hoffmann
Hannover, Germany
(O3)

Bats as a target to infection by RNA viruses. Get in or stay out!

10.00 – 10.20

Jan Felix Drexler
Bonn, Germany
(O4)

Evidence for bat origin of GB viruses.

10.20 – 10.40

Lorraine M. McElhinney
Weybridge, UK
(O5)

Molecular diversity and evolutionary history of rabies virus strains circulating in the Balkans.

10.40 – 11.10

Coffee and Posters

11.10 – 11.30

Sandra Essbauer
München, Germany
(O6)

In search for factors driving Hantaviruses studies along an climate-altitude gradient.

11.30 – 11.50

Natalie B. Cleton
Bilthoven, The Netherlands
(O7)

Age related susceptibility of young poultry to Japanese Encephalitis Virus (JEV).

11.50 – 12.10

Laurence Bichaud
Marseille, France
(O8)

Epidemiologic relationship between Toscana virus infection and Leishmania infantum due to common exposure to Phlebotomus perniciosus sandfly vector.

12.10 – 12.30

Clas Ahlm
Umea, Sweden
(O9)

Sero-epidemiology, co-morbidity and risk factors for Puumala Hantavirus in a highly endemic area of Sweden.

12.30 – 14.15

Lunch break

14.15 – 14.55

KEYNOTE TALK: Christian DROSTEN, Bonn, Germany

Title to be advised (O10)

Time

Speaker

Title

14.55 – 15.15

Barry Atkinson
Porton Down, UK
(O11)

Detection of pathogenic arboviral zoonoses in Central Asia.

15.15 – 15.35

Sandra Junglen
Bonn, Germany
(O12)

Genetic diversity and dilution effects during virus emergence from pristine to modified landscapes.

15.35 – 15.55

Sophie Gryseels
Antwerpen, Belgium
(O13)

Landscape genetics of Mopeia virus and its host, Mastomys Natalensis, in Morogoro Region, Tanzania.

15.55 – 16.30

Coffee and Posters

16.30 – 16.50

Nicole Pavio
Maisons-Alfort, France
(O14)

Strong identity of Hepatitis E Virus strains isolated in human and animal between 2008 and 2009.

16.50 – 17.10

L. Voutilainen
Vantaa, Finland
(O15)

Intensive forest management shaping small mammal communities –impact on Puuv Hantavirus dynamics.

17.10 –17.30

Joëlle Goüy de Bellocq
Antwerpen, Belgium
(O16)

Arenavirus evolution and transmission at a local scale: Mopeia Virus in Morogoro, Tanzania.

17.30 –17.50

Richard Yanagihara
Honolulu, Hawaii
(O17)

Ancestral Soricomorphs as early reservoir hosts of primordial hantaviruses.

17.50 – 19.45

POSTER and WINE session

09.00 – 09.40

KEYNOTE TALK: Daniel PINSCHEWER, Geneva, Switzerland

Title to be advised (O18)

Time

Speaker

Title

09.40 – 10.00

Johnny Habchi
Marseille, France
(O19)

Structural disorder within Henipavirus nucleoprotein and phosphoprotein : prediction, experimental assessment and folding coupled to binding.

10.00 – 10.20

Georg Kochs
Freiburg, Germany
(O20)

The viral nucleoprotein determines influenza A virus escape from MxA restriction.

10.20 – 10.40

Kai Dallmeier
Leuven, Belgium
(O21)

Dissection of Subgenomic Flaviviral RNA structure and function using a novel yeast genetic system.

10.40 – 11.10

Coffee and Posters

11.10 – 11.30

Viktor E. Volchkov
Lyon, France
(O22)

The role of structural protein Vp24 of Ebola and Marburg viruses in anti-oxidative cellular responses.

11.30 – 11.50

Linda Brunotte
Freiburg, Germany
(O23)

Restricted replication of avian influenza polymerases in mammals is rescued by adaptive mutations in NEP.

11.50 – 12.10

Jussi Hepojoki
Helsinki, Finland
(O24)

Galectin-3 binding protein interacts with hantavirus and its concentration is elevated in plasma during acute hantavirus infection.

12.10 – 12.30

Marcel Alexandre Müller
Bonn, Germany
(O25)

Assessment of Sars and Sars-related bat coronavirus accessory proteins as virulence factors.

12.30 – 14.15

Lunch break

14.15 – 14.55

KEYNOTE TALK: Adolfo GARCIA-SASTRE, New-York, USA

Influenza virus/host interactions leading to virus adaptation. (O26)

Time

Speaker

Title

14.55 - 15.15

Pierre Yves Lozach
Zurich, Switzerland
(O27)

Dynamics during virus entry: DC-SIGN as a receptor for Phleboviruses (Bunyaviridae).

15.15 – 15.35

Nathalie Pardigon
Paris, France
(O28)

The interaction of flavivirus M Protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication.

15.35 – 15.55

Jonas Klingström
Solna, Sweden
(O29)

Hantavirus inhibits apoptosis.

15.55 – 16.30

Tea and Posters

16.30 – 16.50

Julio Rodriguez-Andres
Edinburgh, UK
(O30)

The phenoloxidase cascade as a novel mosquito innate immune mechanism against arbovirus infection.

16.50 – 17.10

Agnieszka Szemiel
St Andrews, UK
(O31)

Bunyamwera virus NSs protein in mosquito cells.

17.10 – 17.30

Psylvia Leger
Paris, France
(O32)

Establishment of persistence in Rift Valley Fever Virus infected mosquito cells is correlated with the down regulation of the nonstructural NSs protein via RNA interference pathway.

17.30 – 17.50

Lesley Bell-Sakyi
Edinburgh, UK
(O33)

Detection of the RNA silencing pathway in an Ixodes scapularis cell line and its contribution to restrict viral replication.

19.30

Bus departure for Gala Dinner

19.45 – 23.00

Gala Dinner

09.00 – 09.40

KEYNOTE TALK: Bruno CANARD, Marseille, France

Title to be advised (O34)

Time

Speaker

Title

09.40 – 10.00

Antti Vaheri
Helsinki, Finland
(O35)

Complement activation is critically involved in severe Puumala hantavirus infection.

10.00 – 10.20

Sophie Duraffour
Leuven, Belgium
(O36)

A Novel 1’-Carbon-Substituted 4’-Thiothymidine as promising inhibitor of orthopoxviruses in vitro and in vivo.

10.20 – 10.40

Claudia Filippone
Paris, France
(O37)

High density DNA resequencing microarrays for the diagnosis/discovery of highly pathogenic viruses: application to Crimean Congo Hemorrhagic Fever Virus outbreaks.

10.40 – 11.00

Jeroen Kortekaas
Lelystad, The Netherlands
(O38)

One-plasmid system for the efficient production of non-spreading Rift Valley Fever Virus.

11.00 – 11.30

Coffee and Posters

11.30 – 11.50

Juan-Carlos Saiz
Madrid, Spain
(O39)

Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae elicit protective antibodies in mice that are vertically transferred to the offspring.

11.50 – 12.10

Kimberly A. Dodd
Atlanta, USA
(O40)

Single dose RVF-VRP immunization confers complete protection from lethal Rift Valley fever virus infection revealing the importance of viral replication for antiviral immunity.

12.10 – 12.30

Dimitri Lavillette
Lyon, France
(O41)

Prevention from Chikungunya virus experimental infection in macaques by live attenuated and replicating vaccine.

12.30 – 12.50

Isabelle Leparc-Goffart
Marseille, France
(O42)

Development of a multivalent vaccine based on tri-segmented Junin Candid #1 virus.

12.50 – 13.10

Brian H. Bird
Atlanta, USA
(O43)

A Sheep in Wolf’s clothing: Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, non-teratogenic, and confers sterilizing immunity and protection from lethal challenge in adult and pregnant sheep.